Target type: biologicalprocess
The chemical reactions and pathways involving organophosphates, any phosphate-containing organic compound. [ISBN:0198506732]
Organophosphate metabolic process is the series of biochemical reactions that break down organophosphate compounds in the body. Organophosphates are a class of chemicals that include pesticides, nerve agents, and some pharmaceuticals. They are known for their ability to inhibit the activity of acetylcholinesterase, an enzyme essential for proper nerve function.
The metabolic process of organophosphates begins with their absorption into the body, typically through ingestion, inhalation, or skin contact. Once absorbed, organophosphates can be distributed to various organs and tissues. The primary organ responsible for metabolizing organophosphates is the liver.
In the liver, organophosphates undergo a series of enzymatic transformations, including oxidation, reduction, and hydrolysis. These reactions convert the organophosphate into less toxic metabolites, which can then be excreted from the body in urine and feces.
One important step in the metabolic process is the dephosphorylation of organophosphates. Dephosphorylation involves the removal of a phosphate group from the organophosphate molecule. This process is catalyzed by enzymes known as phosphotriesterases. Dephosphorylation reduces the toxicity of the organophosphate and makes it easier to excrete.
The specific metabolic pathway of an organophosphate can vary depending on the chemical structure of the compound. Some organophosphates are readily metabolized, while others are more persistent and can accumulate in the body.
The metabolism of organophosphates is crucial for eliminating these compounds from the body and preventing their toxic effects. However, in some cases, the metabolic process itself can generate toxic byproducts, contributing to the overall toxicity of the organophosphate.
The efficiency of organophosphate metabolism can be influenced by factors such as age, gender, genetics, and nutritional status. In some individuals, the metabolic process may be impaired, leading to increased susceptibility to organophosphate toxicity.
The study of organophosphate metabolic processes is essential for understanding the mechanisms of organophosphate toxicity and developing strategies for preventing and treating organophosphate poisoning.'
"
Protein | Definition | Taxonomy |
---|---|---|
UDP-3-O-acyl-N-acetylglucosamine deacetylase | A UDP-3-O-acyl-N-acetylglucosamine deacetylase that is encoded in the genome of Escherichia coli K-12. [PRO:DNx, UniProtKB:P0A725] | Escherichia coli K-12 |
Compound | Definition | Classes | Roles |
---|---|---|---|
tu-514 | |||
bb-78485 | BB-78485: structure in first source | ||
l 161240 | |||
chir 090 | CHIR 090: structure in first source CHIR-090 : An L-threonine derivative obtained by formal condensation of the carboxy group of 4-({4-[(morpholin-4-yl)methyl]phenyl}ethynyl)benzoic acid with the amino group of N-hydroxy-L-threoninamide. | acetylenic compound; benzamides; hydroxamic acid; L-threonine derivative; morpholines | antimicrobial agent; EC 3.5.1.108 (UDP-3-O-acyl-N-acetylglucosamine deacetylase) inhibitor; lipopolysaccharide biosynthesis inhibitor |